PORTAIL DOCUMENTAIRE

Article

Contraindicated use of cisapride : Impact of Food and Drug Administration Regulatory Action.

Falter SMALLEY ; Susan-E ANDRADE ; Karnold CHAN ; Michael GOODMAN ; Jerry GURWITZ ; Richard PLATT ; Wayne-A RAY ; Stephanie-D SCHECH ; Deborah SHATIN ; Diane-K WYSOWSKI ; Center for Health Care Policy and Evaluation. UnitedHealth Group. Minnetonka. MN. USA ; Channing Laboratory. Brigham and women's Hospital. Boston. MA. USA ; Departments of Medicine and Preventive Medicine. Vanderbilt University School of Medicine and Geriatric Research. Education and Clinical Center. And Va Medical Center. Nashville. TN. USA |

Dans JAMA - Journal of the american medical association (vol. 284, n° 23, 2000)

[BDSP. Notice produite par INIST 6mDR0x6N. Diffusion soumise à autorisation]. Context Cisapride, a gastrointestinal tract promotility agent, can cause life-threatening cardiac arrhythmias in patients susceptible either because of concurrent use [...]

Plus d'information...

Ajouter à ma sélection